Bill > H2500

This bill aims to increase access to epinephrine autoinjectors (like EpiPens) by allowing certain organizations and entities to acquire, store, and use these devices in emergency situations. The bill defines "authorized entities" as places where allergens that could cause anaphylaxis (a severe, potentially life-threatening allergic reaction) may be present, such as restaurants, sports leagues, colleges, and amusement parks. These entities can obtain epinephrine autoinjectors from approved wholesalers and must store them in easily accessible locations. Authorized entities must designate and train specific employees to manage and potentially administer the autoinjectors to individuals experiencing anaphylaxis, even without a prior prescription or allergy diagnosis. Employees must complete anaphylaxis training from a recognized organization before being allowed to use the devices. The bill provides legal protection for these entities and their trained employees, shielding them from liability unless they demonstrate gross negligence. Furthermore, authorized entities must report incidents involving epinephrine autoinjector use to the department of public health, which will annually publish a summary of these reports. The department is also tasked with developing guidance and regulations to implement this new law.

Health and Social Services

https://malegislature.gov/Bills/194/H2500